Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$282,285
+$69,021 QoQ
Shares Held
73,321
+35.8% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 226 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. MDXG ranks #168 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in MDXG
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $282,285 | 73,321 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $213,264 | 53,991 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $438,763 | 64,810 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $495,545 | 70,995 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $433,779 | 70,995 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $522,591 | 68,762 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $705,203 | 73,306 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $393,801 | 66,633 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $461,766 | 66,633 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $421,436 | 54,732 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $526,138 | 59,993 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $437,348 | 59,993 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $396,553 | 59,993 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $204,576 | 59,993 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $135,775 | 48,840 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $177,546 | 61,863 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $189,340 | 54,565 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $295,839 | 62,811 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $242,916 | 40,218 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $159,123 | 26,258 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $514,586 | 41,134 | Shares | Defined | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||